CIK 0001768224 · Accelerated filer<br>Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 8589002660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-01 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $34.91 | $175K | 514,448 |
| 2023-08-01 | Markels John Director | Grant or award · Stock option (right to buy) | +11,869 | 11,869 | ||
| 2023-08-01 | Markels John Director | Grant or award · Deferred Stock Units | +3,131 | 3,131 | ||
| 2023-08-01 | FARRELL PETER C Director | Grant or award · Stock option (right to buy) | +11,869 | 11,869 | ||
| 2023-08-01 | FARRELL PETER C Director | Grant or award · Deferred Stock Units | +3,131 | 3,131 | ||
| 2023-08-01 | Marantz Jing L. Director | Grant or award · Stock option (right to buy) | +11,869 | 11,869 | ||
| 2023-08-01 | Marantz Jing L. Director | Grant or award · Deferred Stock Units | +3,131 | 3,131 | ||
| 2023-08-01 | HOLMES EDWARD W Director | Grant or award · Stock Option (right to buy) | +11,869 | 11,869 | ||
| 2023-08-01 | HOLMES EDWARD W Director | Grant or award · Deferred Stock Units | +3,131 | 3,131 | ||
| 2023-08-01 | BARLOW JAMES F Director | Grant or award · Stock option (right to buy) | +11,869 | 11,869 | ||
| 2023-08-01 | BARLOW JAMES F Director | Grant or award · Deferred Stock Units | +3,131 | 3,131 | ||
| 2023-08-01 | Marquet Magda Director | Grant or award · Stock option (right to buy) | +11,869 | 11,869 | ||
| 2023-08-01 | Marquet Magda Director | Grant or award · Deferred Stock Units | +3,131 | 3,131 | ||
| 2023-07-14 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −25,000 | $35.01 | $875K | 519,448 |
| 2023-07-14 | Kummerfeld Keith C See Remarks | Option exercise | +4,500 | $9.04 | $41K | 5,450 |
| 2023-07-14 | Kummerfeld Keith C See Remarks | Option exercise | +1,437 | $4.99 | $7K | 6,887 |
| 2023-07-14 | Kummerfeld Keith C See Remarks | Option exercise | +1,031 | $14.12 | $15K | 7,918 |
| 2023-07-14 | Kummerfeld Keith C See Remarks | Sale | −6,968 | $35.00 | $244K | 950 |
| 2023-07-14 | Kummerfeld Keith C See Remarks | Option exercise · Employee Stock Option (right to buy) | −4,500 | 21,000 | ||
| 2023-07-14 | Kummerfeld Keith C See Remarks | Option exercise · Employee Stock Option (right to buy) | −1,437 | 7,126 |
Page 4 of 9 · 178 trades